133 results on '"Willerslev-Olsen, Andreas"'
Search Results
2. Endolysin Inhibits Skin Colonization by Patient-Derived Staphylococcus Aureus and Malignant T-Cell Activation in Cutaneous T-Cell Lymphoma
3. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
4. Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma
5. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma
6. SATB1 in Malignant T Cells
7. Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study
8. Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome
9. Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma
10. miRNA Signature in Early-stage Mycosis Fungoides
11. Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma
12. miRNA signature in early-stage mycosis fungoides
13. JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL)
14. Cellular Interactions and Inflammation in the Pathogenesis of Cutaneous T-Cell Lymphoma
15. The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma
16. MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas
17. MicroRNA-93 Targets p21 and Promotes Proliferation in Mycosis Fungoides T Cells
18. Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma
19. Skin Associated Staphylococcus Aureus Contributes to Disease Progression in CTCL
20. Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis
21. The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma.
22. MicroRNA-93 Targets p21 and Promotes Proliferation in Mycosis Fungoides T Cells.
23. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome
24. Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma
25. Antibiotics inhibit tumor and disease activity in cutaneous T cell lymphoma
26. Prognostic miRNA classifier in early-stage mycosis fungoides: Development and validation in a Danish nationwide study
27. Staphylococcus aureusinduces drug resistance in cancer T cells in Sézary syndrome
28. Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis.
29. Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma.
30. Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma.
31. Single-cell heterogeneity in Sézary syndrome
32. Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells
33. STAT5 induces miR-21 expression in cutaneous T cell lymphoma
34. A novel BLK-induced tumor model
35. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
36. Endolysin Inhibits Skin Colonization by Patient-Derived Staphylococcus Aureusand Malignant T-Cell Activation in Cutaneous T-Cell Lymphoma
37. The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma
38. Epigenetic Silencing of Mir-203 Contributes to IL2Rb Overexpression and Malignant Transformation in Cutaneous T-Cell Lymphoma
39. Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation
40. IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF)
41. Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma
42. Vascular endothelial growth factor receptor-3 expression in mycosis fungoides
43. Vascular endothelial growth factor receptor-3 expression in mycosis fungoides.
44. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
45. Staphylococcus Aureus Induces Stat5 Dependent Mir-155 Expression In Cutaneous T-Cell Lymphoma (Ctcl)
46. Staphylococcus aureusalpha-toxin inhibits CD8+T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma
47. Skin Associated Staphylococcus AureusContributes to Disease Progression in CTCL
48. Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+T cells in cutaneous T-cell lymphoma
49. Bio-O1-07 - miRNA signature in early-stage mycosis fungoides.
50. MicroRNA-106b Regulates Expression of the Tumour Suppressors p21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.